Generex Inks Deal With Sanofi-Aventis for Insulin Supply
December 09, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 9, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Study Finds Generex Oral-lyn(TM) is Safe, Effective, May Reduce Complications of Insulin-Dependent Diabetes
December 03, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 3, 2009 (GLOBE NEWSWIRE) -- Published in the journal Diabetes, Obesity and Metabolism, an independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral...
New York City Drug Store Chain Duane Reade Holdings, Inc. to Carry Crave-NX(TM) 7-Day Diet Aid Spray
December 01, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Dec. 1, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Scientist Makes Presentation at National Influenza Congress
November 23, 2009 10:47 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Nov. 23, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen...
Generex Receives Confirmation of Extension of Compliance Period From NASDAQ
November 10, 2009 15:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio
November 02, 2009 08:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Bill Abajian, Senior Executive Advisor for Global Licensing and Business Development for Generex Biotechnology Corporation (Nasdaq:GNBT)...
Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
October 29, 2009 18:25 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 29, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology Receives Purchase Order for Generex Oral-lyn(TM) for Algerian Market
October 21, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 21, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex: Going Concern Qualification
October 20, 2009 16:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Pursuant to Nasdaq Marketplace Rule 5250(b)(2), Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that its...
Generex to Present Clincial Data at the 20th World Diabetes Congress of the International Diabetes Federation
October 20, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...